drugset / Trial / NCT00144846

Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children

NCT00144846

Phase 3 Completed 80 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the effect of cumulative dose administration of albuterol sulfate inhalation aerosol delivered with valved holding chamber and facemask. This is a four week study in birth to 23 month old subjects who are experiencing acute wheezing due to obstructive airways disease.

Timeline

Start
2004-09
Primary completion
2006-02
Completion
2006-02

Publications

  • Results Abstract submitted to AAAAI 2007: Efficacy of Ventolin( HFA MDI cumulative dosing in children <24 months old. AM Davis, MD, W Lincourt, BS, R Trivedi, MS, A Ellsworth, BS, C Crim, MD. GlaxoSmithKline, RTP, NC

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown Inhaled

Indications